Los Angeles Capital Management
TMCI icon

Los Angeles Capital Management’s Treace Medical Concepts TMCI Stock Holding History

Los Angeles Capital Management’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-218
Closed -$1.38K – 2607
2025
Q4 		$1.38K Buy
+218
New +$947 ﹤0.01% 2462
2025
Q3 		– Sell
-41,062
Closed -$241K – 1534
2025
Q2 		$241K Sell
41,062
-44,403
-52% -$289K ﹤0.01% 1125
2025
Q1 		$717K Buy
+85,465
New +$768K ﹤0.01% 651
2023
Q3 		– Sell
-24,260
Closed -$621K – 1238
2023
Q2 		$621K Buy
+24,260
New +$626K ﹤0.01% 777

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Los Angeles Capital Management's TMCI Position: Q1 2026 in Review

Los Angeles Capital Management sold out of Treace Medical Concepts (TMCI) in Q1 2026, closing a stake of 218 shares — an estimated $1.38K sold.

Los Angeles Capital Management first reported a position in TMCI in Q2 2023 and held it in 4 quarters. The position peaked at $717K in Q1 2025. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • Los Angeles Capital Management reported no remaining Treace Medical Concepts position as of Q1 2026 after selling out during the quarter.
  • Los Angeles Capital Management sold 218 Treace Medical Concepts shares in Q1 2026, an estimated $1.38K.
  • Los Angeles Capital Management first reported a position in Treace Medical Concepts in Q2 2023 and held it in 4 quarters.
  • Los Angeles Capital Management's Treace Medical Concepts position peaked at $717K in Q1 2025.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.